APO RESEARCH · REPORT
New Medical Materials and Biomaterials
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
Product & engineering
Understand the product.
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
Selected research
Industry Research
New Medical Materials and Biomaterials Industry Research Report 2026
Market perspective
New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).
In US, New Medical Materials and Biomaterials key players include STR, Avitus, Sagemax, Stratasys, Formlab, etc.
In terms of product, Bioceramics is the largest segment, with a share over 20%. And in terms of application, the largest application is Catheters, followed by Dental Products, Transplant Components, etc.
Read the full market overview
Report Scope
This report quantifies the global New Medical Materials and Biomaterials market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to New Medical Materials and Biomaterials.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
New Medical Materials and Biomaterials Market by Company
STR
Avitus
Sagemax
Stratasys
Formlab
NanoH2O (LG)
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific
Invibio
Secant Medical
TeraPore Technologies
New Medical Materials and Biomaterials Segment by Type
Medical Polymers
Bioceramics
Medical 3D Printing Materials
Membranes
Surface Modifications
Others
New Medical Materials and Biomaterials Segment by Application
Packaging
Transplant Components
Dental Products
Catheters
Others
New Medical Materials and Biomaterials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Medical Materials and Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of New Medical Materials and Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Medical Materials and Biomaterials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of New Medical Materials and Biomaterials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Polymers
- Bioceramics
- Medical 3D Printing Materials
- Membranes
- Surface Modifications
- Others
Applications
- Packaging
- Transplant Components
- Dental Products
- Catheters
- Others
Companies covered
- STR
- Avitus
- Sagemax
- Stratasys
- Formlab
- NanoH2O (LG)
- Covalent-coating
- Nasseo
- TriboFilm
- ACS material
- Palmaz Scientific
- Invibio
- Secant Medical
- TeraPore Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 New Medical Materials and Biomaterials by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Medical Polymers
- 2.2.3 Bioceramics
- 2.2.4 Medical 3D Printing Materials
- 2.2.5 Membranes
- 2.2.6 Surface Modifications
- 2.2.7 Others
- 2.3 New Medical Materials and Biomaterials by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Packaging
- 2.3.3 Transplant Components
- 2.3.4 Dental Products
- 2.3.5 Catheters
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 New Medical Materials and Biomaterials Breakdown Data by Type
- 3.1 Global New Medical Materials and Biomaterials Historic Market Size by Type (2021-2026)
- 3.2 Global New Medical Materials and Biomaterials Forecasted Market Size by Type (2027-2032)
4 New Medical Materials and Biomaterials Breakdown Data by Application
- 4.1 Global New Medical Materials and Biomaterials Historic Market Size by Application (2021-2026)
- 4.2 Global New Medical Materials and Biomaterials Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global New Medical Materials and Biomaterials Market Perspective (2021-2032)
- 5.2 Global New Medical Materials and Biomaterials Growth Trends by Region
- 5.2.1 Global New Medical Materials and Biomaterials Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 New Medical Materials and Biomaterials Historic Market Size by Region (2021-2026)
- 5.2.3 New Medical Materials and Biomaterials Forecasted Market Size by Region (2027-2032)
- 5.3 New Medical Materials and Biomaterials Market Dynamics
- 5.3.1 New Medical Materials and Biomaterials Industry Trends
- 5.3.2 New Medical Materials and Biomaterials Market Drivers
- 5.3.3 New Medical Materials and Biomaterials Market Challenges
- 5.3.4 New Medical Materials and Biomaterials Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top New Medical Materials and Biomaterials Players by Revenue
- 6.1.1 Global Top New Medical Materials and Biomaterials Players by Revenue (2021-2026)
- 6.1.2 Global New Medical Materials and Biomaterials Revenue Market Share by Players (2021-2026)
- 6.2 Global New Medical Materials and Biomaterials Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of New Medical Materials and Biomaterials Head Office and Area Served
- 6.4 Global New Medical Materials and Biomaterials Players, Product Type & Application
- 6.5 Global New Medical Materials and Biomaterials Manufacturers Established Date
- 6.6 Global New Medical Materials and Biomaterials Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America New Medical Materials and Biomaterials Market Size (2021-2032)
- 7.2 North America New Medical Materials and Biomaterials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 7.4 North America New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe New Medical Materials and Biomaterials Market Size (2021-2032)
- 8.2 Europe New Medical Materials and Biomaterials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 8.4 Europe New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific New Medical Materials and Biomaterials Market Size (2021-2032)
- 9.2 Asia-Pacific New Medical Materials and Biomaterials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 9.4 Asia-Pacific New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America New Medical Materials and Biomaterials Market Size (2021-2032)
- 10.2 South America New Medical Materials and Biomaterials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 10.4 South America New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa New Medical Materials and Biomaterials Market Size (2021-2032)
- 11.2 Middle East & Africa New Medical Materials and Biomaterials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa New Medical Materials and Biomaterials Market Size by Country (2021-2026)
- 11.4 Middle East & Africa New Medical Materials and Biomaterials Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 STR
- 12.1.1 STR Company Information
- 12.1.2 STR Business Overview
- 12.1.3 STR Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.1.4 STR New Medical Materials and Biomaterials Product Portfolio
- 12.1.5 STR Recent Developments
- 12.2 Avitus
- 12.2.1 Avitus Company Information
- 12.2.2 Avitus Business Overview
- 12.2.3 Avitus Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.2.4 Avitus New Medical Materials and Biomaterials Product Portfolio
- 12.2.5 Avitus Recent Developments
- 12.3 Sagemax
- 12.3.1 Sagemax Company Information
- 12.3.2 Sagemax Business Overview
- 12.3.3 Sagemax Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.3.4 Sagemax New Medical Materials and Biomaterials Product Portfolio
- 12.3.5 Sagemax Recent Developments
- 12.4 Stratasys
- 12.4.1 Stratasys Company Information
- 12.4.2 Stratasys Business Overview
- 12.4.3 Stratasys Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.4.4 Stratasys New Medical Materials and Biomaterials Product Portfolio
- 12.4.5 Stratasys Recent Developments
- 12.5 Formlab
- 12.5.1 Formlab Company Information
- 12.5.2 Formlab Business Overview
- 12.5.3 Formlab Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.5.4 Formlab New Medical Materials and Biomaterials Product Portfolio
- 12.5.5 Formlab Recent Developments
- 12.6 NanoH2O (LG)
- 12.6.1 NanoH2O (LG) Company Information
- 12.6.2 NanoH2O (LG) Business Overview
- 12.6.3 NanoH2O (LG) Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.6.4 NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio
- 12.6.5 NanoH2O (LG) Recent Developments
- 12.7 Covalent-coating
- 12.7.1 Covalent-coating Company Information
- 12.7.2 Covalent-coating Business Overview
- 12.7.3 Covalent-coating Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.7.4 Covalent-coating New Medical Materials and Biomaterials Product Portfolio
- 12.7.5 Covalent-coating Recent Developments
- 12.8 Nasseo
- 12.8.1 Nasseo Company Information
- 12.8.2 Nasseo Business Overview
- 12.8.3 Nasseo Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.8.4 Nasseo New Medical Materials and Biomaterials Product Portfolio
- 12.8.5 Nasseo Recent Developments
- 12.9 TriboFilm
- 12.9.1 TriboFilm Company Information
- 12.9.2 TriboFilm Business Overview
- 12.9.3 TriboFilm Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.9.4 TriboFilm New Medical Materials and Biomaterials Product Portfolio
- 12.9.5 TriboFilm Recent Developments
- 12.10 ACS material
- 12.10.1 ACS material Company Information
- 12.10.2 ACS material Business Overview
- 12.10.3 ACS material Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.10.4 ACS material New Medical Materials and Biomaterials Product Portfolio
- 12.10.5 ACS material Recent Developments
- 12.11 Palmaz Scientific
- 12.11.1 Palmaz Scientific Company Information
- 12.11.2 Palmaz Scientific Business Overview
- 12.11.3 Palmaz Scientific Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.11.4 Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio
- 12.11.5 Palmaz Scientific Recent Developments
- 12.12 Invibio
- 12.12.1 Invibio Company Information
- 12.12.2 Invibio Business Overview
- 12.12.3 Invibio Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.12.4 Invibio New Medical Materials and Biomaterials Product Portfolio
- 12.12.5 Invibio Recent Developments
- 12.13 Secant Medical
- 12.13.1 Secant Medical Company Information
- 12.13.2 Secant Medical Business Overview
- 12.13.3 Secant Medical Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.13.4 Secant Medical New Medical Materials and Biomaterials Product Portfolio
- 12.13.5 Secant Medical Recent Developments
- 12.14 TeraPore Technologies
- 12.14.1 TeraPore Technologies Company Information
- 12.14.2 TeraPore Technologies Business Overview
- 12.14.3 TeraPore Technologies Revenue in New Medical Materials and Biomaterials Business (2021-2026)
- 12.14.4 TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio
- 12.14.5 TeraPore Technologies Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst